Literature DB >> 23258926

Deficiencies in proposed new EU regulation of clinical trials.

Peter C Gøtzsche1.   

Abstract

Mesh:

Year:  2012        PMID: 23258926     DOI: 10.1136/bmj.e8522

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Independent drug bulletins to promote the prescription of appropriate drugs: a necessary but difficult task.

Authors:  Bernard Burnand
Journal:  Bull World Health Organ       Date:  2013-06-01       Impact factor: 9.408

Review 2.  Application challenges of the new EU Clinical Trials Regulation.

Authors:  Eugenijus Gefenas; Asta Cekanauskaite; Jurate Lekstutiene; Vilma Lukaseviciene
Journal:  Eur J Clin Pharmacol       Date:  2017-05-31       Impact factor: 2.953

3.  Increasing value and reducing waste in biomedical research regulation and management.

Authors:  Rustam Al-Shahi Salman; Elaine Beller; Jonathan Kagan; Elina Hemminki; Robert S Phillips; Julian Savulescu; Malcolm Macleod; Janet Wisely; Iain Chalmers
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

Review 4.  A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.

Authors:  Rebecca A Crow; Kimberly A Hart; Michael P McDermott; Rabi Tawil; William B Martens; Barbara E Herr; Elaine McColl; Jennifer Wilkinson; Janbernd Kirschner; Wendy M King; Michele Eagle; Mary W Brown; Deborah Hirtz; Hanns Lochmuller; Volker Straub; Emma Ciafaloni; Perry B Shieh; Stefan Spinty; Anne-Marie Childs; Adnan Y Manzur; Lucia Morandi; Russell J Butterfield; Iain Horrocks; Helen Roper; Kevin M Flanigan; Nancy L Kuntz; Jean K Mah; Leslie Morrison; Basil T Darras; Maja von der Hagen; Ulrike Schara; Ekkehard Wilichowski; Tiziana Mongini; Craig M McDonald; Giuseppe Vita; Richard J Barohn; Richard S Finkel; Matthew Wicklund; Hugh J McMillan; Imelda Hughes; Elena Pegoraro; W Bryan Burnette; James F Howard; Mathula Thangarajh; Craig Campbell; Robert C Griggs; Kate Bushby; Michela Guglieri
Journal:  Trials       Date:  2018-05-10       Impact factor: 2.279

5.  Description of the protocols for randomized controlled trials on cancer drugs conducted in Spain (1999-2003).

Authors:  Xavier Bonfill; Mónica Ballesteros; Ignasi Gich; María Antonia Serrano; Fernando García López; Gerard Urrútia
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.